These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 29540229

  • 1. A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional study.
    Inoue T, Miyazaki J, Ichioka D, Narita S, Kageyama S, Sugimoto M, Mitsuzuka K, Shiraishi Y, Kinoshita H, Wakeda H, Nomoto T, Kikuchi E, Matsui Y, Fujie K, Habuchi T, Nishiyama H.
    BMC Cancer; 2018 Mar 14; 18(1):290. PubMed ID: 29540229
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
    Cho KS, Joung JY, Seo HK, Cho IC, Chung HS, Chung J, Lee KH.
    Cancer Chemother Pharmacol; 2011 Apr 14; 67(4):769-74. PubMed ID: 20532510
    [Abstract] [Full Text] [Related]

  • 4. [Impact of different methods of estimating renal function on determining eligibility for cisplatin (CDDP)-based chemotherapy in patients with invasive urothelial carcinoma].
    Goto T, Yoshimura K, Matsui Y, Shimizu Y, Inoue T, Okubo K, Kamba T, Nishiyama H, Ogawa O.
    Hinyokika Kiyo; 2011 Dec 14; 57(12):671-6. PubMed ID: 22240299
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Are the Formulas Used to Estimate Renal Function Adequate for Patients Treated With Cisplatin-Based Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Carcinoma?
    Niwa N, Kikuchi E, Masashi M, Tanaka N, Nishiyama T, Miyajima A, Saito S, Oya M.
    Clin Genitourin Cancer; 2016 Oct 14; 14(5):e501-e507. PubMed ID: 27236770
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    Nakagawa T, Komemushi Y, Kawai T, Otsuka M, Miyakawa J, Uemura Y, Kanatani A, Taguchi S, Naito A, Suzuki M, Nishimatsu H, Hirano Y, Tanaka Y, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    World J Urol; 2017 Oct 14; 35(10):1569-1575. PubMed ID: 28397000
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome.
    Yafi FA, Tanguay S, Rendon R, Jacobsen N, Fairey A, Izawa J, Kapoor A, Black P, Lacombe L, Chin J, So A, Lattouf JB, Bell D, Fradet Y, Saad F, Matsumoto E, Drachenberg D, Cagiannos I, Kassouf W.
    Urol Oncol; 2014 Jan 14; 32(1):31.e17-24. PubMed ID: 23428535
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of renal function using cystatin C-based estimated glomerular filtration rate in patients with urothelial carcinoma treated with gemcitabine and cisplatin chemotherapy.
    Nishimura F, Ushijima T, Hamada S, Kadowaki D, Miyamura S, Oniki K, Saruwatari J.
    J Clin Pharm Ther; 2021 Dec 14; 46(6):1622-1628. PubMed ID: 34339546
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The impact of a solitary kidney on tolerability to gemcitabine plus cisplatin chemotherapy in urothelial carcinoma patients: a retrospective study.
    Kondo M, Hotta Y, Ando R, Yasui T, Kimura K.
    Cancer Chemother Pharmacol; 2017 May 14; 79(5):995-1001. PubMed ID: 28391352
    [Abstract] [Full Text] [Related]

  • 12. New classification of hydronephrosis on 18F-FDG-PET/CT predicts post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma.
    Asai S, Fukumoto T, Watanabe R, Koyama K, Sawada Y, Noda T, Miura N, Yanagihara Y, Miyauchi Y, Miyagawa M, Kikugawa T, Saika T.
    Jpn J Clin Oncol; 2018 Nov 01; 48(11):1022-1027. PubMed ID: 30252103
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies.
    Hinai Y, Motoyama S, Niioka T, Miura M.
    J Clin Pharm Ther; 2013 Dec 01; 38(6):498-503. PubMed ID: 24102360
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
    Shoji S, Hosojima M, Kabasawa H, Kondo R, Miura S, Watanabe S, Aoki N, Kaseda R, Kuwahara S, Tanabe N, Hirayama Y, Narita I, Kikuchi T, Kagamu H, Saito A.
    BMC Cancer; 2019 Dec 02; 19(1):1170. PubMed ID: 31791266
    [Abstract] [Full Text] [Related]

  • 18. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy.
    Kaag MG, O'Malley RL, O'Malley P, Godoy G, Chen M, Smaldone MC, Hrebinko RL, Raman JD, Bochner B, Dalbagni G, Stifelman MD, Taneja SS, Huang WC.
    Eur Urol; 2010 Oct 02; 58(4):581-7. PubMed ID: 20619530
    [Abstract] [Full Text] [Related]

  • 19. Risk factors associated with ineligibility of adjuvant cisplatin-based chemotherapy after nephroureterectomy.
    Shao IH, Lin YH, Hou CP, Juang HH, Chen CL, Chang PL, Tsui KH.
    Drug Des Devel Ther; 2014 Oct 02; 8():1985-90. PubMed ID: 25364228
    [Abstract] [Full Text] [Related]

  • 20. Investigation of estimated glomerular filtration rate and its perioperative change in patients with upper urinary tract urothelial carcinoma: A multi-institutional retrospective study.
    Koguchi D, Matsumoto K, Ikeda M, Taoka Y, Hirayama T, Murakami Y, Utsunomiya T, Matsuda D, Okuno N, Irie A, Iwamura M.
    Asia Pac J Clin Oncol; 2018 Oct 02; 14(5):e420-e427. PubMed ID: 29436164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.